These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7833497)

  • 1. Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Rinaudo MT; Curto M; Rabbone I; Piccinini M; Bruno R; Mioletti S; Gamba S
    J Diabetes Complications; 1994; 8(4):221-5. PubMed ID: 7833497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular effects of sulphonylurea agents in circulating lymphocytes of patients with non-insulin-dependent diabetes mellitus.
    Rabbone I; Piccinini M; Curto M; Mostert M; Gamba S; Mioletti S; Bruno R; Rinaudo MT
    Br J Clin Pharmacol; 1998 Mar; 45(3):291-9. PubMed ID: 9517374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes.
    Curto M; Novi RF; Rabbone I; Maurino M; Piccinini M; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1137-42. PubMed ID: 9426381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring.
    Mostert M; Rabbone I; Piccinini M; Curto M; Vai S; Musso A; Rinaudo MT
    J Endocrinol Invest; 1999; 22(7):519-26. PubMed ID: 10475149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin on pyruvate dehydrogenase in circulating lymphocytes from normal and diabetic rats.
    Rinaudo MT; Curto M; Bruno R; Marino C; Mostert M
    Int J Biochem; 1988; 20(7):667-74. PubMed ID: 3053285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behaviour of pyruvate dehydrogenase in circulating lymphocytes from diabetic children.
    Rinaudo MT; Curto M; Bruno R; Marino C; Piccinini M; Cerutti F; Mostert M; Sacchetti C
    Diabetologia; 1989 Apr; 32(4):245-8. PubMed ID: 2668078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Wajchenberg BL; Santomauro AT; Porrelli RN
    Diabetes Res Clin Pract; 1993 May; 20(2):147-54. PubMed ID: 8375268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes. Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes.
    Buffington CK; Givens JR; Kitabchi AE
    Diabetes; 1990 Mar; 39(3):361-8. PubMed ID: 2407584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin signal and its effects on the pyruvate dehydrogenase complex in circulating lymphocytes of obese children.
    Curto M; Piccinini M; Cerutti F; Rabbone I; Mostert M; Sacchetti C; Bruno R; Rinaudo MT
    Int J Biochem; 1992 May; 24(5):831-7. PubMed ID: 1592161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocyte glycogen synthase and pyruvate dehydrogenase in obese and type II diabetic subjects.
    Mandarino LJ; Madar Z; Kolterman OG; Bell JM; Olefsky JM
    Am J Physiol; 1986 Oct; 251(4 Pt 1):E489-96. PubMed ID: 3094377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin modulation of pyruvate dehydrogenase in human circulating lymphocytes.
    Curto M; Piccinini M; Bruno R; Mostert M; Rinaudo MT
    Int J Biochem; 1988; 20(11):1211-7. PubMed ID: 3073980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G proteins and regulation of pyruvate dehydrogenase activity by insulin in human circulating lymphocytes.
    Curto M; Piccinini M; Rabbone I; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Biochem Cell Biol; 1997 Oct; 29(10):1207-17. PubMed ID: 9438382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
    Palmer KJ; Brogden RN
    Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of non-insulin-dependent diabetes mellitus (type II): management with gliclazide.
    Rifkin H
    Am J Med; 1991 Jun; 90(6A):3S-7S. PubMed ID: 1872302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In obese individuals dexfenfluramine corrects molecular derangements reflecting insulin resistance.
    Piccinini M; Rabbone I; Novi RF; Alberto G; Mostert M; Musso A; Vai S; Gamba S; Rinaudo MT
    Int J Obes Relat Metab Disord; 2000 Jun; 24(6):735-41. PubMed ID: 10878680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced blood insulin overcomes pyruvate dehydrogenase derangements that reflect systemic insulin resistance in obese adolescents.
    Mostert M; Cerutti F; Piccinini M; Rabbone I; Sacchetti C; Pacini G; Rinaudo MT
    Clin Sci (Lond); 2002 Jul; 103(1):93-9. PubMed ID: 12095410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.